JP2020527727A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527727A5 JP2020527727A5 JP2020522785A JP2020522785A JP2020527727A5 JP 2020527727 A5 JP2020527727 A5 JP 2020527727A5 JP 2020522785 A JP2020522785 A JP 2020522785A JP 2020522785 A JP2020522785 A JP 2020522785A JP 2020527727 A5 JP2020527727 A5 JP 2020527727A5
- Authority
- JP
- Japan
- Prior art keywords
- binding molecule
- seq
- diagnostic method
- cell receptor
- autonomously
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17001167 | 2017-07-07 | ||
| EP17001167.0 | 2017-07-07 | ||
| EP17001166.2 | 2017-07-07 | ||
| EP17001166 | 2017-07-07 | ||
| EP18162666.4 | 2018-03-19 | ||
| EP18162666.4A EP3424527A1 (de) | 2017-07-07 | 2018-03-19 | Diagnostisches verfahren |
| PCT/EP2018/068316 WO2019008128A1 (de) | 2017-07-07 | 2018-07-05 | Diagnostisches verfahren |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527727A JP2020527727A (ja) | 2020-09-10 |
| JP2020527727A5 true JP2020527727A5 (cg-RX-API-DMAC7.html) | 2021-08-12 |
| JP7239575B2 JP7239575B2 (ja) | 2023-03-14 |
Family
ID=64500047
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020522785A Active JP7239575B2 (ja) | 2017-07-07 | 2018-07-05 | サンプル中の自律的に活性なb細胞受容体または自律的に活性化されたb細胞受容体を認識する方法 |
| JP2020522786A Active JP7271532B2 (ja) | 2017-07-07 | 2018-07-05 | 生物学的結合分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020522786A Active JP7271532B2 (ja) | 2017-07-07 | 2018-07-05 | 生物学的結合分子 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11634487B2 (cg-RX-API-DMAC7.html) |
| EP (4) | EP3424528A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7239575B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3070848A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2019008129A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3424528A1 (de) * | 2017-07-07 | 2019-01-09 | AVA Lifescience GmbH | Biologische bindemoleküle |
| WO2020221463A1 (de) * | 2019-05-02 | 2020-11-05 | Ava Lifescience Gmbh | Verfahren zur selektion biologischer bindemoleküle |
| EP3733709A1 (de) * | 2019-05-02 | 2020-11-04 | AVA Lifescience | Biologische bindemoleküle |
| US12698325B2 (en) * | 2019-05-02 | 2026-08-04 | Ava Lifescience Gmbh | Biological binding molecules |
| EP4387990A4 (en) * | 2021-08-18 | 2025-07-30 | Univ Pennsylvania | COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B CELL RECEPTORS |
| WO2023152204A1 (en) | 2022-02-10 | 2023-08-17 | Ava Lifescience Gmbh | Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll |
| EP4227321A1 (en) * | 2022-02-10 | 2023-08-16 | AVA Lifescience GmbH | Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll |
| CA3262006A1 (en) * | 2022-07-25 | 2024-02-01 | Sinabiosolution Gmbh | Humanized chimeric antigen receptors targeting the B-lymphocyte receptor in chronic lymphocytic leukemia and their uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7393531B2 (en) | 2003-01-21 | 2008-07-01 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| RU2691698C2 (ru) | 2012-02-24 | 2019-06-17 | ЭББВИ СТЕМСЕНТРКС ЭлЭлСи | Антитела против sez6 и способы их применения |
| WO2014179714A1 (en) * | 2013-05-03 | 2014-11-06 | The Board Of Regents Of The University Of Texas System | Generating peptoid vaccines |
| JP2016531915A (ja) * | 2013-08-28 | 2016-10-13 | ステムセントリックス, インコーポレイテッド | 部位特異的抗体コンジュゲーション方法および組成物 |
| EP3424528A1 (de) * | 2017-07-07 | 2019-01-09 | AVA Lifescience GmbH | Biologische bindemoleküle |
-
2018
- 2018-03-19 EP EP18162672.2A patent/EP3424528A1/de not_active Withdrawn
- 2018-03-19 EP EP18162666.4A patent/EP3424527A1/de not_active Withdrawn
- 2018-07-05 EP EP18746104.1A patent/EP3615073A1/de active Pending
- 2018-07-05 EP EP18746103.3A patent/EP3615072A1/de active Pending
- 2018-07-05 CA CA3070848A patent/CA3070848A1/en active Pending
- 2018-07-05 WO PCT/EP2018/068317 patent/WO2019008129A1/de not_active Ceased
- 2018-07-05 US US16/625,754 patent/US11634487B2/en active Active
- 2018-07-05 US US16/625,756 patent/US11591391B2/en active Active
- 2018-07-05 JP JP2020522785A patent/JP7239575B2/ja active Active
- 2018-07-05 JP JP2020522786A patent/JP7271532B2/ja active Active
- 2018-07-05 WO PCT/EP2018/068316 patent/WO2019008128A1/de not_active Ceased